Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage
NCT03379467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 655
Last updated 2017-12-21
Summary
Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies before their fifth birthday. In part, this is due to the low coverage rate of routine childhood immunizations. Since Pakistan is a Low Middle Income Country (LMIC) it is essential that an immunization intervention be developed that is suitable for its socioeconomic setting. The tele-density of Pakistan exceeds 70% and the cost of SMS in Pakistan is very low. Moreover the use of SMS in the country has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification. This study will utilise this prevalence of mobile phones to assess whether simple and interactive sms reminders can serve to increase childhood immunization coverage and timeliness.
The pilot study will be carried out only in 2 EPI (Extended program on Immunization) centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group. 656 participants will be enrolled at Penta-1 and will be followed up until measles-2 vaccination. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.
Conditions
- Immunization; Infection
- SMS
Interventions
- OTHER
-
SMS Reminder
A text message sent as a reminder for immunization on the registered phone number
- OTHER
-
Interactive Reminder
A text message sent as a reminder for immunization on the registered phone number which requires the receiver to respond back
Sponsors & Collaborators
-
Interactive Research and Development
lead OTHER
Principal Investigators
-
Subhash Chandir, Phd · Interactive Research and Development (IRD)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Weeks
- Max Age
- 12 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-23
- Primary Completion
- 2014-03-08
- Completion
- 2014-03-08
More Related Trials
-
Khushi Baby (KB): Novel Mobile Health Solution for Vaccination Record Keeping in India
NCT02518178 ·Status: UNKNOWN ·Phase: NA
-
Randomized Controlled Trial of Measles Vaccination Schedule
NCT03170765 ·Status: UNKNOWN ·Phase: NA
-
Use of Virtual Reality in the Reduction of Pain After the Administration of Vaccines Among Children in Primary Care Centers.
NCT06313762 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine
NCT03654664 ·Status: COMPLETED ·Phase: PHASE3
-
Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso
NCT03614533 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents
NCT06298708 ·Status: COMPLETED ·Phase: PHASE3
-
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine
NCT03821441 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula Polymorpha)
NCT05916326 ·Status: COMPLETED ·Phase: PHASE3
-
Social Media-based Vaccine Confidence and Hesitancy Monitoring
NCT05442762 ·Status: WITHDRAWN
-
Child Vaccination Scheduling in China
NCT07141875 ·Status: NOT_YET_RECRUITING
-
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs
NCT05613127 ·Status: UNKNOWN ·Phase: PHASE3
-
Making Decisions About the Measles-Mumps-Rubella Vaccine
NCT01369394 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV
NCT06978621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3
NCT01586572 ·Status: COMPLETED ·Phase: NA
-
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age
NCT00128167 ·Status: COMPLETED ·Phase: PHASE3
-
Implementing Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in Mexico
NCT00436358 ·Status: COMPLETED
-
Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants
NCT00938327 ·Status: COMPLETED
-
Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants
NCT00871338 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine
NCT02153866 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
NCT06618196 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study
NCT00291343 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
NCT04535037 ·Status: COMPLETED ·Phase: PHASE4
-
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
NCT00463437 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
NCT04941261 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
NCT05621655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2